CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $173,000 | +35.2% | 7,957 | +96.5% | 0.00% | – |
| Q2 2023 | $128,000 | +54.2% | 4,050 | +18.6% | 0.00% | – |
| Q1 2023 | $83,000 | -67.7% | 3,414 | -58.1% | 0.00% | – |
| Q4 2022 | $257,000 | +209.6% | 8,150 | +175.4% | 0.00% | – |
| Q3 2022 | $83,000 | +25.8% | 2,959 | +19.4% | 0.00% | – |
| Q2 2022 | $66,000 | -59.8% | 2,479 | -47.0% | 0.00% | – |
| Q1 2022 | $164,000 | -73.3% | 4,673 | -75.4% | 0.00% | – |
| Q4 2021 | $615,000 | +284.4% | 18,978 | +249.8% | 0.00% | – |
| Q3 2021 | $160,000 | +158.1% | 5,426 | +124.8% | 0.00% | – |
| Q2 2021 | $62,000 | – | 2,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |